Trials / Unknown
UnknownNCT04653779
A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
A Multi-center, Open-label, Single-arm, Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication, Efficacy and Safety After Switching to SUGAMET®XR Tablet 5/1000mg in Patients With Type 2 Diabetes and Renal Diseases
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, open-label, single arm study to Evaluate the preference regarding convenience of medication, efficacy and safety of Sugamet XR tab. 5/1000mg in patients with Type 2 diabetes and renal diseases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Evogliptin 5mg/Metformin 1000mg | Size reduction of a tablet formulation |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-05-01
- Completion
- 2021-07-01
- First posted
- 2020-12-04
- Last updated
- 2020-12-11
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04653779. Inclusion in this directory is not an endorsement.